↓ Skip to main content

Management of Castration Resistant Prostate Cancer

Overview of attention for book
Cover of 'Management of Castration Resistant Prostate Cancer'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction—Castration Resistant Prostate Cancer: A Rapidly Expanding Clinical State and a Model for New Therapeutic Opportunities
  3. Altmetric Badge
    Chapter 2 Evolution of Clinical States and the Castration Resistant Clinical Paradigm
  4. Altmetric Badge
    Chapter 3 Molecular Mechanisms of Prostate Cancer Progression After Castration
  5. Altmetric Badge
    Chapter 4 New Imaging Modalities
  6. Altmetric Badge
    Chapter 5 Androgen Receptor Biology in Castration Resistant Prostate Cancer
  7. Altmetric Badge
    Chapter 6 The Androgen Receptor as a Therapeutic Target for Castration-Resistant Prostate Cancer
  8. Altmetric Badge
    Chapter 7 Approaches Targeting Androgen Synthesis (CYP 17 Inhibitors)
  9. Altmetric Badge
    Chapter 8 Cytotoxic Chemotherapy (Taxanes and Taxane Combinations)
  10. Altmetric Badge
    Chapter 9 The Emerging Role of Immunotherapy in Castrate-Resistant Prostate Cancer
  11. Altmetric Badge
    Chapter 10 Bone-Targeted Therapy: Rationale and Current Status
  12. Altmetric Badge
    Chapter 11 Radium-223 and Other Radiopharmaceuticals in Prostate Cancer
  13. Altmetric Badge
    Chapter 12 Introduction
  14. Altmetric Badge
    Chapter 13 Phase I–II Targeted Treatments
  15. Altmetric Badge
    Chapter 14 Defining Clinical Endpoints in Castration-Resistant Prostate Cancer
  16. Altmetric Badge
    Chapter 15 Angiogenesis Inhibition in Castration-Resistant Prostate Cancer
  17. Altmetric Badge
    Chapter 16 Co-targeting Adaptive Survival Pathways
  18. Altmetric Badge
    Chapter 17 Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer
  19. Altmetric Badge
    Chapter 18 PARP Inhibitors
  20. Altmetric Badge
    Chapter 19 Targeting C-Met/VEGF in Castration Resistant Prostate Cancer
  21. Altmetric Badge
    Chapter 20 Epigenetics in Castration Resistant Prostate Cancer
  22. Altmetric Badge
    Chapter 21 Undifferentiated Prostate Cancer and the Neuroendocrine Phenotype
  23. Altmetric Badge
    Chapter 22 Strategies Addressing Quality of Life: Management of Patient-Reported Outcomes and Symptoms
  24. Altmetric Badge
    Chapter 23 Evidence-Based Therapeutic Approaches for mCRPC Patients: Rational Sequence of Standard Treatment Options and Design for Future Drug Development
Attention for Chapter 13: Phase I–II Targeted Treatments
Altmetric Badge

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Phase I–II Targeted Treatments
Chapter number 13
Book title
Management of Castration Resistant Prostate Cancer
Published by
Humana Press, New York, NY, January 2014
DOI 10.1007/978-1-4939-1176-9_13
Book ISBNs
978-1-4939-1175-2, 978-1-4939-1176-9
Authors

Carmel Pezaro, Aurelius Omlin, Johann S. de Bono

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 100%
Readers by discipline Count As %
Unknown 1 100%